{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:22:11Z","timestamp":1789024931435,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495"],"award-info":[{"award-number":["Grants U01NR004061; U01AG012505, U01AG012535, U01AG012531, U01AG012539, U01AG012546, U01AG012553, U01AG012554, U01AG012495"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00198-017-4276-9","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T01:27:40Z","timestamp":1509067660000},"page":"347-354","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3008-6584","authenticated-orcid":false,"given":"K.","family":"Ruppert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. C.","family":"Zgibor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Derby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. H.","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"key":"4276_CR1","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/diacare.27.10.2540","volume":"27","author":"DS Fong","year":"2004","unstructured":"Fong DS, Aiello LP, Ferris FL 3rd, Klein R (2004) Diabetic retinopathy. Diabetes Care 27:2540\u20132553","journal-title":"Diabetes Care"},{"key":"4276_CR2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","volume":"329","author":"The DCCT Research Group","year":"1993","unstructured":"The DCCT Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977\u2013986","journal-title":"N Engl J Med"},{"key":"4276_CR3","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","unstructured":"UK Prospective Diabetes Study Group (1998) Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837\u2013853","journal-title":"Lancet"},{"key":"4276_CR4","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.2337\/dc06-2222","volume":"30","author":"HA Keenan","year":"2007","unstructured":"Keenan HA, Costacou T, Sun JK, Doria A, Cavellerano J, Coney J, Orchard TJ, Aiello LP, King GL (2007) Clinical factors associated with resistance to microvascular complications in diabetic patients of extreme disease duration: the 50-year medalist study. Diabetes Care 30:1995\u20131997","journal-title":"Diabetes Care"},{"key":"4276_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.2337\/diacare.28.1.164","volume":"28","author":"JL Gross","year":"2005","unstructured":"Gross JL, de Azevedo MJ, Silveiro SP, Canani LH, Caramori ML, Zelmanovitz T (2005) Diabetic nephropathy: diagnosis, prevention, and treatment. Diabetes Care 28:164\u2013176","journal-title":"Diabetes Care"},{"issue":"5","key":"4276_CR6","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1007\/s00198-010-1357-4","volume":"22","author":"N Khalil","year":"2011","unstructured":"Khalil N, Sutton-Tyrrell K, Strotmeyer ES, Greendale GA, Vuga M, Selzer F, Crandall CJ, Cauley JA (2011) Menopausal bone changes and incident fractures in diabetic women: a cohort study. Osteoporos Int 22(5):1367\u20131376","journal-title":"Osteoporos Int"},{"key":"4276_CR7","doi-asserted-by":"publisher","first-page":"775","DOI":"10.2337\/diab.44.7.775","volume":"44","author":"JC Krakauer","year":"1995","unstructured":"Krakauer JC, McKenna MJ, Buderer NF, Rao DS, Whitehouse FW, Parfitt AM (1995) Bone loss and bone turnover in diabetes. Diabetes 44:775\u2013782","journal-title":"Diabetes"},{"key":"4276_CR8","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s002239900498","volume":"63","author":"MT Rosato","year":"1998","unstructured":"Rosato MT, Schneider SH, Shapses SA (1998) Bone turnover and insulin-like growth factor I levels increase after improved glycemic control in non-insulin dependent diabetes mellitus. Calcif Tissue Int 63:107\u2013111","journal-title":"Calcif Tissue Int"},{"issue":"1","key":"4276_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/gye.17.1.19.29","volume":"17","author":"O Akin","year":"2003","unstructured":"Akin O, G\u00f6l K, Akt\u00fcrk M, Erkaya S (2003) Evaluation of bone turnover in postmenopausal patients with type 2 diabetes mellitus using biochemical markers and bone mineral density measurements. Gynecol Endocrinol 17(1):19\u201329","journal-title":"Gynecol Endocrinol"},{"key":"4276_CR10","unstructured":"Mansoor Karimifar, Morteza Aghajanpoor, Amirhossein Salari, Ahmadreza Zamani, Mansour Salesi, Peyman Motaghi (2012) Evaluation of bone loss in diabetic postmenopausal women. J Res Med Sci, Vol 17, No 11"},{"key":"4276_CR11","first-page":"443","volume":"61","author":"Z Zakeri","year":"2011","unstructured":"Zakeri Z, Azizi Z, Mehrabifar H, Hashemi M (2011) Evaluation of bone mineral density in premenopausal women with type-2 diabetes mellitus in Zahedan, southeast Iran. JPMA 61:443","journal-title":"JPMA"},{"key":"4276_CR12","doi-asserted-by":"crossref","unstructured":"Touminen, J. Mpolsc, P. Ronnemaa, T. (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes care, Vol 22, Number 7","DOI":"10.2337\/diacare.22.7.1196"},{"issue":"6","key":"4276_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/MED.0b013e3282f1cba3","volume":"14","author":"ES Strotmeyer","year":"2007","unstructured":"Strotmeyer ES, Cauley JA (2007) Diabetes mellitus, bone mineral density, and fracture risk. Curr Opin Endocrinol Diabetes Obes. 14(6):429\u2013435","journal-title":"Curr Opin Endocrinol Diabetes Obes."},{"issue":"6","key":"4276_CR14","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/MED.0b013e328331c7eb","volume":"16","author":"NB Khazai","year":"2009","unstructured":"Khazai NB, Beck GR Jr, Umpierrez GE (2009) Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes 16(6):435\u2013445","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4276_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1359\/jbmr.1997.12.8.1289","volume":"12","author":"D Hans","year":"1997","unstructured":"Hans D, Duboeuf F, Schott AM, Horn S, Avioli LV, Drezner MK, Meunier PJ (1997) Effects of a new positioner on the precision of hip bone mineral density measurements. J Bone Miner Res 12:1289\u20131294","journal-title":"J Bone Miner Res"},{"key":"4276_CR16","doi-asserted-by":"publisher","first-page":"62","DOI":"10.3389\/fendo.2013.00062","volume":"4","author":"AV Schwartz","year":"2013","unstructured":"Schwartz AV, Ewing SK, Porzig AM, McCulloch CE, Resnick HE, Hillier TA, Sellmeyer DE (2013) Diabetes and change in bone mineral density at the hip, calcaneus, spine, and radius in older women. Front Endocrinol 4:62","journal-title":"Front Endocrinol"},{"key":"4276_CR17","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00198-005-1909-1","volume":"16","author":"II de Liefde","year":"2005","unstructured":"de Liefde II, van der Klift M, de Laet CEDH et al (2005) Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam study. Osteoporos Int 16:1713","journal-title":"Osteoporos Int"},{"key":"4276_CR18","doi-asserted-by":"crossref","unstructured":"Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z et al (2012) Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol 27(5):319\u2013332","DOI":"10.1007\/s10654-012-9674-x"},{"key":"4276_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","volume":"18","author":"P Vestergaard","year":"2007","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2007) Discrepancies in bone mineral density and fracture risk in patients with type1 and type 2 diabetes- a meta-analysis. Osteoporos Int 18:427","journal-title":"Osteoporos Int"},{"issue":"1","key":"4276_CR20","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4239\/wjd.v5.i1.14","volume":"5","author":"GL Klein","year":"2014","unstructured":"Klein GL (2014) Insulin and bone: recent developments. World J Diabetes 5(1):14\u201316","journal-title":"World J Diabetes"},{"issue":"5","key":"4276_CR21","doi-asserted-by":"publisher","first-page":"E735","DOI":"10.1152\/ajpendo.00159.2005","volume":"289","author":"KM Thrailkill","year":"2005","unstructured":"Thrailkill KM, Lumpkin CK, Bunn RC, Kemp SF, Fowlkes JL (2005) Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues. Am J Physiol Endocrinol Metab 289(5):E735\u2013E745","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"4276_CR22","doi-asserted-by":"crossref","unstructured":"McCarty MF (1995) Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density. Med Hypotheses 45(3)","DOI":"10.1016\/0306-9877(95)90112-4"},{"key":"4276_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s40200-016-0275-1","volume":"15","author":"M Ghodsi","year":"2016","unstructured":"Ghodsi M, Larijani B, Ali Keshtkar A, Nasli-Esfahani E, Alatab S, Reza Mohajeri-Tehrani M (2016) Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord 15:52","journal-title":"J Diabetes Metab Disord"},{"key":"4276_CR24","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nrendo.2016.153","volume":"13","author":"N Napoli","year":"2017","unstructured":"Napoli N, Chandran M, Pierroz DD, Abrahamsen B, Schwartz AV, Ferrari SL (2017) Mechanisms of diabetes mellitus-induced bone fragility. Nat Rev Endocrinol 13:208\u2013219","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"4276_CR25","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1759720X16687480","volume":"9","author":"V Sundararaghavan","year":"2017","unstructured":"Sundararaghavan V, Mazur MM, Evans B, Liu J, Ebraheim NA (2017) Diabetes and bone health: latest evidence and clinical implications. Ther Adv Musculoskelet Dis 9(3):67\u201374","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"4276_CR26","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nrendo.2011.233","volume":"8","author":"C Hamann","year":"2012","unstructured":"Hamann C, Kirschner S, Gunther K, Hofbauer L (2012) Bone, sweet bone\u2013osteoporotic fractures in diabetes mellitus. Nat Rev Endocrinol 8:297\u2013305","journal-title":"Nat Rev Endocrinol"},{"key":"4276_CR27","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.2337\/diacare.19.12.1388","volume":"19","author":"E Barrett-Connor","year":"1996","unstructured":"Barrett-Connor E, Kritz-Silverstein D (1996) Does hyperinsulinemia preserve bone? Diabetes Care 19:1388\u20131392","journal-title":"Diabetes Care"},{"issue":"1","key":"4276_CR28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1210\/jc.2011-1883","volume":"97","author":"S Ishii","year":"2012","unstructured":"Ishii S, Cauley JA, Crandall CJ et al (2012) Diabetes and femoral neck strength: findings from the hip strength across the menopausal transition study. J Clin Endocrinol Metab 97(1):190\u2013197","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"4276_CR29","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1007\/s00198-016-3645-0","volume":"27","author":"EAC De Waard","year":"2016","unstructured":"De Waard EAC, Koster A, Melai T, van Geel TA, Henry RMA, Schram MT, van den Bergh JPW (2016) The association between glucose metabolism status, diabetes severity and a history of fractures and recent falls in participants of 50 years and older\u2014the Maastricht Study. Osteoporos Int 27(11):3207\u20133216","journal-title":"Osteoporos Int"},{"key":"4276_CR30","doi-asserted-by":"crossref","unstructured":"Starup-Linde J, Gregersen S, Vestergaard P (2016) Associations with fracture in patients with diabetes: a nested case\u2013control study. BMJ Open","DOI":"10.1136\/bmjopen-2015-009686"},{"issue":"4","key":"4276_CR31","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1002\/jbmr.2083","volume":"29","author":"P Srikanthan","year":"2014","unstructured":"Srikanthan P, Crandall CJ, Miller-Martinez D, Seeman TE, Greendale GA, Binkley N, Karlamangla AS (2014) Insulin resistance and bone strength. Findings from the study of midlife in the United States. J Bone Miner Res Off J Am Soc Bone Miner Res 29(4):796\u2013803","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"},{"key":"4276_CR32","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s11684-013-0243-9","volume":"7","author":"W Yan","year":"2013","unstructured":"Yan W, Li X (2013) Impact of diabetes and its treatments on skeletal diseases. Front Med 7:81","journal-title":"Front Med"},{"issue":"5","key":"4276_CR33","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1210\/jc.2015-4180","volume":"101","author":"SR Majumdar","year":"2016","unstructured":"Majumdar SR, Josse RG, Lin M, Eurich DT (2016) Does sitagliptin affect the rate of osteoporotic fractures in type 2 diabetes? Population-based cohort study. J Clin Endocrinol Metab 101(5):1963\u20131969","journal-title":"J Clin Endocrinol Metab"},{"key":"4276_CR34","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","volume":"48","author":"P Vestergaard","year":"2005","unstructured":"Vestergaard P, Rejnmark L, Mosekilde L (2005) Relative fracture risk in patients with diabetes mellitus and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia 48:1292","journal-title":"Diabetologia"},{"issue":"4","key":"4276_CR35","doi-asserted-by":"publisher","first-page":"431","DOI":"10.4103\/0971-5916.159287","volume":"141","author":"BS Kumar","year":"2015","unstructured":"Kumar BS, Ravisankar A, Mohan A, Kumar DP, Katyarmal DT, Sachan A, Sarma KVS (2015) Effect of oral hypoglycaemic agents on bone metabolism in patients with type 2 diabetes mellitus and occurrence of osteoporosis. Indian J Med Res 141(4):431\u2013437","journal-title":"Indian J Med Res"},{"issue":"5","key":"4276_CR36","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1185\/03007990902801147","volume":"25","author":"S Adami","year":"2009","unstructured":"Adami S (2009) Bone health in diabetes: considerations for clinical management. Curr Med Res Opin 25(5):1057\u20131072","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"4276_CR37","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0377-1237(11)60120-2","volume":"68","author":"M Dutta","year":"2012","unstructured":"Dutta M, Pakhetra R, Garg M (2012) Evaluation of bone mineral density in type 2 diabetes mellitus patients before and after treatment. Med J Armed Forces India 68(1):48\u201352","journal-title":"Med J Armed Forces India"},{"key":"4276_CR38","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1002\/jbmr.3002","volume":"32","author":"M Wallander","year":"2017","unstructured":"Wallander M, Axelsson KF, Nilsson AG, Lundh D, Lorentzon M (2017) Type 2 diabetes and risk of hip fractures and non-skeletal fall injuries in the elderly: a study from the fractures and fall injuries in the elderly cohort (FRAILCO). J Bone Miner Res 32:449\u2013460. \n                    https:\/\/doi.org\/10.1002\/jbmr.3002","journal-title":"J Bone Miner Res"},{"key":"4276_CR39","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/aje\/kwg231","volume":"158","author":"WA Ray","year":"2003","unstructured":"Ray WA (2003) Evaluating medication effects outside of clinical trials: new-user designs. Am J Epidemiol 158:915\u2013920","journal-title":"Am J Epidemiol"},{"key":"4276_CR40","unstructured":"Faries D, Leon A, Haro JM, Obenchain RL (2010) Analysis of Observational Health Care Data using SAS. SAS Institute"},{"key":"4276_CR41","doi-asserted-by":"publisher","DOI":"10.1002\/0470023589","volume-title":"Applied mixed models in medicine","author":"H Brown","year":"2006","unstructured":"Brown H, Prescott R (2006) Applied mixed models in medicine, 2nd edn. Hoboken, NJ, John Wiley, Sons, Ltd","edition":"2"},{"issue":"1","key":"4276_CR42","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jbmr.534","volume":"27","author":"GA Greendale","year":"2012","unstructured":"Greendale GA, Sowers M et al (2012) Bone mineral density loss in relation to the final menstrual period in a multi-ethnic cohort: results from the study of women\u2019s health across the nation (SWAN). J Bone Miner Res Off J Am Soc Bone Miner Res 27(1):111\u2013118","journal-title":"J Bone Miner Res Off J Am Soc Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4276-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4276-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T07:42:09Z","timestamp":1589442129000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4276-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["4276"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4276-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]},"assertion":[{"value":"24 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dan H. Solomon receives salary support from institutional research grants from Eli Lilly, Amgen, Pfizer, AstraZeneca, Genentech, and Corrona. He also receives royalties from UpToDate and serves in unpaid roles in studies funded by Pfizer and Eli Lilly. Kristine Ruppert, Jane Cauley, Yijuan Lian, Carol Derby, and Janice Zgibor declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}